echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Amlodipine besylate tablet of Yabao Pharmaceutical Co., Ltd. has been appraised, becoming the first one in Shanxi Province

    Amlodipine besylate tablet of Yabao Pharmaceutical Co., Ltd. has been appraised, becoming the first one in Shanxi Province

    • Last Update: 2019-03-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On March 14, Yabao pharmaceutical announced that amlodipine besylate tablets declared by the company had obtained the approval document for supplementary application of drugs approved and issued by the State Food and Drug Administration and passed the consistency evaluation For Yabao pharmaceutical, this is the first variety that he has ever evaluated; for amlodipine besylate tablets, Yabao pharmaceutical is the seventh enterprise that has ever evaluated, and the applications of 28 enterprises have also been accepted, with fierce competition; from the perspective of regional quantity, Yabao pharmaceutical is the first enterprise that has passed the consistency evaluation in Shanxi Province, and amlodipine besylate tablets are also the first variety that has passed the evaluation in Shanxi Province 。 The full text of the announcement is as follows:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.